Clinical Trials Browser

Phase 2 × INDUSTRY × stenoparib × Clear all

NCT03878849 2025-08-28

Investigation of the Anti-tumor Effect of 2X-121 in Patients With Recurrent, Advanced Ovarian Cancer

Phase 2 Recruiting

Advanced Ovarian Cancer

NCT03562832 2025-01-23

Investigation of Anti-tumour Effect and Tolerability of the PARP Inhibitor 2X-121 in Patients With Metastatic Breast Cancer Selected by the 2X-121 DRP

Phase 2 Completed

Breast Neoplasms